Encouraging the production and adoption of generic medicines is not an option, but a necessity to strengthen our pharmaceutical independence. In an interview with ECO Inspirations, Adil BELRHZAL, Managing Director of Dislog Healthcare, highlights the challenges and opportunities facing the Moroccan pharmaceutical industry.
A changing market: Today, generics account for just 45% of the market in value terms, well below their potential.
A lever for health sovereignty: dependence on imported raw materials must be reduced to ensure sustainable access to treatments.
A regulatory framework to be strengthened: Introducing a right of substitution for pharmacists would accelerate the adoption of generics and guarantee more accessible care for all.
At Dislog Group, we are fully committed to this dynamic, investing in local pharmaceutical production and supporting policies aimed at strengthening health sovereignty.
The future of healthcare depends on a strong, innovative and independent pharmaceutical industry.
Source: Adil Belrhzal: "Encouraging generics is an imperative for health sovereignty".